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Abstract 
Objectives: to determine the prevalence and characteristics of previously unknown methicillin-resistant Staphylococcus aureus
(MRSA) carriers at admission. 
Design: two prospective case–control studies. 
Subjects: 1,621 elderly patients were screened for MRSA carriage within 24 hours after admission to a geriatric hospital in
Geneva, Switzerland. 
Methods: risk factors associated with previously unknown MRSA carriage were determined in the derivation group, and the
resulting risk score was evaluated in the validation cohort using logistic regression analysis. 
Results: prevalence of MRSA carriage at admission increased from 7.3% (53/724 patients) in 2001 to 8.7% (78/897 patients) in
2003, with a corresponding prevalence of unknown MRSA carriers of 4.6 and 5.8%, respectively. Three variables were independ-
ently associated with previously unknown MRSA carriage: recent antibiotic treatment (adjusted OR (aOR) 2.3; 95% CI 1.0–5.1),
intra-hospital transfer (aOR 2.5; 95% CI 1.2–5.3), and hospitalization in the past 2 years (aOR 2.7; 95% CI 1.1–6.7). In the valida-
tion cohort, the probability of MRSA carriage increased across risk scores: 0 point, 4% prevalence (6/146); 1 point, 15% (21/
136); and 2 points, 31% (21/68; P<0.001). The risk score showed good discrimination and calibration in both groups. 
Conclusions: our risk score, which used a simple additive point system to estimate the likelihood of unknown MRSA car-
riage, had good accuracy and generalised well in an independent sample of patients. Once validated in a clinical trial, our risk
score may be used as a tool to optimise MRSA control. 
Keywords: MRSA, prevalence, infection control, carriage, prediction, aged, elderly 
Introduction 
Methicillin-resistant Staphylococcus aureus (MRSA) represents
an important burden on sub-acute and chronic care facilities
[1]. Epidemiologic surveys indicate that rates of MRSA
cross-infection are increasing in these settings [2–4]. Since
MRSA carriers without symptomatic infection are an
important reservoir and source of spread, risk profiles to
identify elderly patients at high risk of MRSA carriage have
been developed [5–8]. Despite the great merit of these stud-
ies, they were often limited to nursing home residents and
did not attempt to develop practical tools to predict on-
admission MRSA carriage in elderly patients hospitalised in
a geriatric hospital. 
Between 1990 and 2000, the proportion of MRSA among
all clinical S. aureus isolates at our geriatric university hospital
substantially increased from <1 to >50% [9]. Therefore, in
April 2001, a cross-sectional screening survey was performed.
Among 260 screened patients, 48 MRSA carriers (18%) were
detected. Only 15 out of 48 (31%) patients had previously
been identified as MRSA carriers. 
Therefore, we undertook two prospective case–control
studies to determine the prevalence of newly identified MRSA
carriage on admission and the proportion of unknown
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MRSA carriers that would have been missed without admis-
sion screening. Moreover, the present study describes the
derivation and the validation of a practical model to identify
previously unknown MRSA carriers on admission to a geri-
atric hospital. 
Methods 
Setting and study population 
The geriatric hospital of the Geneva University Hospitals is
a university-based institution with 294 beds, which serves as
the primary and tertiary geriatric care centre for the greater
Geneva area. Two-thirds of patients are directly admitted
from the community; one-third are transfers from the acute
care setting or from nursing homes. During the study
period, approximately 2,600 patients (mean age 83 years)
were hospitalised each year, with a median length of stay of
36 days. 
Study design 
We undertook two prospective case–control studies: the
first period (derivation cohort) extended from 1 July
through 31 October 2001, the second period (validation
cohort) from 1 March through 31 August 2003. During
these time periods, all consecutive hospitalised patients
were screened for MRSA carriage within 24 hours after
admission. Patients were excluded if they refused screening
or stayed <24 hours. 
Screening procedure 
Swabs were performed using a cotton stick moistened with
sterile 0.9% saline solution. They were collected from both
anterior nares and perineal region in all patients and, if
present, from catheter insertion sites, skin lesions and urine
in catheterised patients [9]. 
Microbiological procedure 
All swabs were processed in the central laboratory within 24
hours. They were first streaked onto ORSA plates (Oxacil-
lin Resistance Screening Agar, Oxoid, Basingstoke, UK)
and then suspended in 2 ml of colistin-salt broth (brain-
heart infusion with 10µg of colistin/ml and 2.5% NaCl), as
a back-up medium. Suspect colonies were confirmed by
Pastorex agglutination (Bio-Rad, Reinach, Switzerland),
positive reaction on DNase agar, and growth on Mueller-
Hinton oxacillin agar (6µg of oxacillin/ml) according to
NCCLS standards [10]. The presence of MRSA was
confirmed using the Vitek 2 identification and susceptibility
testing cards for Gram-positive bacteria (bioMérieux,
Marcy l’Etoile, France). 
Data collection 
From medical records, we extracted information on socio-
demographic data, admission date, diabetes, McCabe and
Jackson score of severity of underlying illness [11], Charlson
comorbidity index [12], patient’s prior location and transfer
status, previous hospitalisation in the past 2 years (excluding
the current hospital stay if the patient was transferred from
acute care), previous surgery within 1 year, presence of
urinary catheter or skin lesions on admission, past history of
MRSA carriage and recent antibiotic treatment within the
last month. 
Definitions 
A known MRSA carrier was defined as any patient with at
least one culture result positive for MRSA prior to the
present admission (since 1994). A previously unknown
MRSA case was a patient in whom MRSA was isolated for
the first time on hospital admission. 
Retrieval of previously known MRSA-positive 
patients 
Since 1994, the names of all MRSA-positive patients have
been kept in a secure, computerised database at our insti-
tution. An automatic alert is generated each time a previ-
ously identified MRSA carrier is re-admitted, in order to
rapidly install contact precautions [9]. When no previous
admission to our institution was found in new MRSA car-
riers, we interviewed the patient or his primary care physi-
cian to determine whether MRSA carriage had previously
been identified in another institution or in the outpatient
setting. 
Statistical analysis 
Results are expressed as mean values ± SD. For contrasts of
dimensional variables, the Student’s t test and the Wilcoxon
rank-sum test were used. To compare proportions, we used
a χ2-test or Fisher’s exact test, when indicated. Continuous
variables were converted to categorical variables if they did
not fulfil criteria of linearity. 
The primary outcome of interest was previously
unknown MRSA carriage on admission. If a patient was
admitted more than once during the study period, only the
first admission was included in the logistic regression
analysis. Patients previously identified as MRSA carriers
were excluded from the prediction model. Patient charac-
teristics were computed separately for the derivation and
validation set. For the derivation cohort, all 641 patients
without past history of MRSA carriage served as controls.
For the validation set, we randomly selected 302 control
patients without history of MRSA carriage who were admit-
ted during the same time period. 
The association between independent variables and
previously unknown MRSA carrier status was evaluated
by logistic regression indicating the bivariate odds ratios
(ORs) with their 95% confidence intervals (95% CI). Var-
iables reaching ORs of 2 and P values 0.1 were entered
in a forward stepwise logistic regression analysis, gene-
rating a prediction model of previously unknown MRSA
carriage. The predictive accuracy and calibration of the
models was assessed using area under the receiver operat-
ing curves (AUC) and Hosmer–Lemeshow goodness-of-
fit tests [13, 14]. 
To facilitate the use of the model in clinical practice, the
ORs associated with the identified predictors in the logistic
regression model were transformed into point scores to
obtain an aggregate score by adding up points. The beta
coefficients of all independent risk factors were similar in
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magnitude and, therefore, risk stratification was performed
by a simple count of the number of predictors. 
Statistics were run with the STATA 8.0 software package
(STATA Corp., College Station, TX). P values <0.05 (two-
tailed) were considered significant. 
Results 
Cohort assembly 
During both study periods, 1,714 patients (derivation cohort
772; validation cohort 942) were admitted for >24 hours. The
compliance with MRSA screening was excellent: 724 out of
772 patients (94%) and 897 out of 942 patients (95%) were
screened, respectively. 
MRSA carriage on admission 
Prevalence of MRSA carriage at time of admission increased
from 7.3% (53/724 patients) in 2001 to 8.7% (78/897 patients)
in 2003. Of all MRSA carriers, 31 out of 53 (58%) and 48 out
of 78 (62%) were not known for a past history of MRSA colo-
nisation. After excluding 52 MRSA-positive patients and 64
formerly MRSA-positive patients who had successfully been
decolonised and were MRSA-free on admission, the true prev-
alence of unknown MRSA carriers on admission was 4.6%
(31/672) and 5.8% (48/833), respectively. 
In both periods, four patients without previously identified
MRSA carriage had an active MRSA infection on admission.
Thus, using only clinical isolates of infected sites and targeted
screening of previously known MRSA carriers, 51% (27/53)
and 56% (44/78) of all MRSA carriers would have been
missed without the general screening policy on admission. 
Baseline features 
Baseline features of the two study populations and charac-
teristics of previously unknown MRSA carriers compared
with MRSA-free patients are shown in Table 1. The deriva-
tion and validation cohorts were similar with respect to age,
sex, Charlson comorbidity index, prior surgery, transfer
from acute care or nursing home, recent antibiotic treat-
ment, and presence of skin lesions. Significantly more
patients in the derivation cohort than in the validation
cohort had a rapidly or ultimately fatal disease (P= 0.004)
and had previously been hospitalised (P = 0.01). The validation
cohort had a greater proportion of patients with diabetes
(P < 0.001) or urinary catheters (P < 0.001) than did the
derivation cohort. 
In both cohorts, newly identified MRSA carriers were
more sick, had more previous hospitalisations, surgical
interventions, antibiotic treatments and urinary catheters on
admission than non-carriers. 
Development and validation of the prediction 
model 
Table 2 presents the results of the bivariate and multivariate
logistic regression analysis for the derivation cohort. The
final risk model to predict previously unknown MRSA
carriage consisted of the following three variables: recent
antibiotic treatment (adjusted OR 2.3; 95% CI 1.0–5.1;
P= 0.05), intra-hospital transfer (adjusted OR 2.5; 95% CI
1.2–5.3; P= 0.02), and hospitalisation within the last 2 years
(adjusted OR 2.7; 95% CI 1.1–6.7; P= 0.03). Four of the 31
cases had none of these risk factors (sensitivity 87%; specif-
icity 30%; negative predictive value 95%). The model had a
corresponding AUC-value of 0.71 (95% CI 0.61–0.80). In
the validation cohort, 6 out of 48 cases had no characteristic
included in the final prediction model (sensitivity 88%;
specificity 46%; AUC-value 0.72; 95% CI 0.65–0.79). 
Risk score 
Using the three independently predictive variables from the
logistic regression model, we created a risk score by stratifying
patients who had 0, 1 or 2 of these risk factors. For example,
an 82-year-old male patient with several hospitalisations due
to prostate cancer who received ciprofloxacin 3 weeks prior
to admission and spent 8 days in urology before transfer to
the geriatric hospital had a risk score of 1+1+1=3. 
For the derivation cohort, the observed proportions of
patients with newly identified MRSA carriage were 2% (4 out
of 199) in patients with none of the risk factors, 3% (8 out
of 311) in patients with 1 risk factor and 12% (19 out of
162) in patients with 2 risk factors (P < 0.001). For the
validation cohort, which was based on a case–control study
of 350 patients, the observed proportions were 4% (6 out of
146) for score 0, 15% (21 out of 136) for score 1 and 31%
(21 out of 68) for a score 2 (P < 0.001). The Hosmer–
Lemeshow test yielded a P value of 0.34 for the derivation
cohort and a P value of 0.31 for the validation cohort,
demonstrating good fit of the prediction model. 
Operating characteristics 
Table 3 presents the operating characteristics of the risk
score for different cut points to predict previously unknown
MRSA carriage on admission. Limiting screening at admis-
sion to patients with 1 risk factor would have reduced the
screening volume by at least 30% and would have identified
87% (27/31) of all previously unknown carriers in the
derivation cohort and 88% (42/48) in the validation cohort.
Limiting on-admission screening to patients with 2 risk
factors (24% and 19% of patients in the derivation and
validation cohort, respectively) would have identified 19
(61%) and 21 (44%) MRSA carriers in both cohorts. 
Discussion 
In this study, we have derived and validated a model to
predict previously unknown MRSA carriage on admission
to a geriatric hospital. Three patient characteristics
predicted MRSA carriage and stratified patients into risk
groups. The derived risk score worked well in the validation
cohort in terms of both calibration and discrimination. 
Earlier work has demonstrated the challenge of estimating
risk factors of MRSA carriage on admission to geriatric
hospitals. For instance, Eveillard and colleagues performed
a 5-week on-admission screening study in two geriatric
wards in France [15]. Variables independently associated
with MRSA carriage were hospitalisation within the last 6
months and open skin lesions, whereas hospital transfer and
recent antibiotic therapy were not associated with MRSA
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carriage. Unfortunately, this study, like others [16, 17], did
not discriminate between known and unknown MRSA
carriers on admission. 
Other studies have identified numerous risk factors for
MRSA colonisation in elderly patients during hospitalisa-
tion, including length of stay, previous surgery, functional
status, presence of skin lesions or invasive devices, prior
antibiotic exposure, severe comorbidity, and proximity to
an already infected or colonised patient [3, 5, 6, 8, 16, 18–
20]. Elderly patients accumulate many of these risk factors
due to frailty and frequent contact with the health care sys-
tem. Although these studies were useful in identifying
patients at risk of nosocomial MRSA colonisation or infec-
tion, none of them had been validated prospectively and
targeted specifically previously unknown MRSA carriers on
admission. Therefore, our risk score offers an improve-
ment over existing studies, because it had a larger sample
size, was validated on a prospectively collected database and
developed a simple point score to stratify elderly patients
into low- and high-risk groups for unidentified MRSA
carriage. 
The few investigations that have specifically evaluated
the prevalence of MRSA carriage on admission to sub-acute
or chronic care facilities differ from our study in important
ways, so comparisons are limited. However, our study
confirms that the prevalence of previously unknown MRSA
carriage at admission to geriatric care is high [16, 21]. It
increased from 4.6% in 2001 to 5.8% in 2003, reflecting
endemic MRSA transmission in the Geneva health care set-
ting [22, 23]. Previously reported prevalence of unknown
MRSA carriage at admission ranged between 7.8 and 13.6%
[2, 4, 24]. 
Screening for MRSA carriage in the geriatric setting
remains a controversial issue, since the rates of MRSA
infections and infection-related deaths are low [19, 25, 26].
Yet MRSA endemicity in any chronic care facility may result
in adverse outcomes, increased use of glycopeptides and
emergence of vancomycin resistance [27]. Although not
supported by strong evidence, some anecdotal reports have
demonstrated that programmes combining screening,
cohorting, early implementation of contact isolation and
topical decolonisation could reduce the rate of MRSA
cross-infection in geriatric facilities [28, 29]. For instance,
Talon et al. demonstrated the usefulness of systematic
screening on admission, allowing early recognition of patients
with MRSA [2]. Although MRSA carriage in a geriatric hos-
pital has less dramatic clinical implications, these authors
argued that it may act as a reservoir for the acute-care set-
ting. Therefore, identification of this unknown reservoir
may have an impact on the entire healthcare network [21].
Nevertheless, many authors consider screening only high-
risk patients would be sufficient [21]. It would be more
cost-effective, but requires readily available risk factors to
be clearly established. Our risk score could be a starting
point for further studies, investigating the clinical and finan-
cial implications of a targeted screening programme. 
Table 2. Risk factors associated with newly identified MRSA carriage at admission to a geriatric hospital, excluding formerly
known MRSA carriers (bivariate and multivariate logistic regression analysis in the derivation cohort) 
aThis variable showed strong colinearity with the variable ‘previous hospitalisation’ and was therefore excluded from the multivariate analysis. 
bThis variable did not increase the accuracy of the multivariate model in the derivation set. 
 
. . . . . . . . . . . . . . . . . . . . . . . . .
Odds ratio (95% CI) 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 
Risk factor Bivariate Multivariate 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Male sex 0.7 (0.3–1.7)  
Age 80 years 1.2 (0.5–2.7)  
Previous hospitalisation (<2 years) 2.9 (1.2–7.3) 2.7 (1.1–6.7) 
Prior surgery (past 12 months)a 4.4 (2.0–9.6)  
Charlson score (per 1-point 
increment) 
1.2 (1.0–1.4) 
 
Ultimately or rapidly fatal disease 1.3 (0.6–3.0)  
Diabetes mellitus 1.8 (0.7–4.8)  
Recent antibiotic therapy (<1 month) 2.8 (1.3–6.2) 2.3 (1.0–5.1) 
Origin of patient   
Home 0.6 (0.3–1.5)  
Nursing home 0.3 (0.1–2.3)  
Intra-hospital transfer 3.2 (1.5–6.6) 2.5 (1.2–5.3) 
Presence at admission of   
Peripheral catheter 1.7 (0.7–3.8)  
Urinary catheterb 3.2 (1.2–8.8)  
Open skin lesions 1.9 (0.8–4.6)  
Table 3. Yield of the risk score for different screening cut
points to predict previously unknown MRSA carriage at
admission to a geriatric hospital 
Score (number of risk factors) Sensitivity Patients to be screened 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . .. . .. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Derivation cohort   
0 100% (31/31) 100% (672/672) 
1 87% (27/31) 70% (473/672) 
2 61% (19/31) 24% (162/672) 
Validation cohort   
0 100% (48/48) 100% (350/350) 
1 88% (42/48) 58% (204/350) 
2 44% (21/48) 19% (68/350)
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This study has some limitations that deserve comment.
The prognostic model was derived and validated in one
centre and may not reflect the epidemiology of MRSA in other
settings. However, our risk score had good discrimination
and calibration, making it likely that the score may be general-
isable to other locations. Moreover, the prevalence of com-
munity-acquired MRSA was not investigated. Previous
analyses have shown, however, that community-acquired
MRSA remains negligible in the Swiss elderly population [30]. 
In summary, our risk score demonstrated good accuracy
and provides a useful prediction tool to estimate the likeli-
hood of unknown MRSA carriage on admission to a geriatric
hospital. Assuming population characteristics similar to
those of our cohort, the use of our score could decrease the
volume of MRSA screening cultures by at least 30%. Once
validated in a large intervention trial, it may be used as an
instrument to optimise MRSA control in the sub-acute and
chronic care setting. 
Key points 
• The prevalence of previously unknown MRSA carriage
at admission to geriatric care is high. 
• Three patient characteristics predicted unknown MRSA
carriage on admission and stratified patients into risk
groups. 
• The derived risk score had good accuracy and general-
ised well in an independent sample of patients. It could
decrease the volume of MRSA screening cultures by at
least 30%. 
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Abstract 
Background: the practical issues confronting older people who suffer chronic pain may not be tackled in a pain clinic setting
and little is known of their strategies for coping. They seem to have little or no information on how to improve the quality of
their lives or on resources available to them. 
Aim: the aim of this study was to ascertain from older people the practical, physical and psychosocial limitations they faced
because of chronic pain, and the strategies they used to deal with them. 
Method: a qualitative approach to generating data was chosen using a Grounded Theory approach and unstructured inter-
views. Sixty-three people ranging from 60 to 87 years of age participated in the study. Audio-tapes were transcribed verbatim.
The material was coded and collapsed into themes. 
Results: two main themes emerged: (i) the desire for independence and control; and (ii) adaptation to a life with chronic
pain. The valuing of independence is in line with previous findings. With only three exceptions none of the participants were
certain how or where to get help with practical issues and so they lived in fear of loss of their independence. Several sub-
categories formed the theme of adaptation. These were acceptance and non-acceptance, pacing oneself, helping other
people, the use of prayer and ‘looking good and feeling good’. When independence and control is effective, older people may
adapt better to chronic pain. 
